Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 4 (4) , e235
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranosticsProceedings of the National Academy of Sciences, 2013
- Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1PLOS ONE, 2013
- Dimeric DNA Aptamer Complexes for High-capacity–targeted Drug Delivery Using pH-sensitive Covalent LinkagesMolecular Therapy Nucleic Acids, 2013
- Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific AptamerPLOS ONE, 2012
- An RNA Alternative to Human Transferrin: A New Tool for Targeting Human CellsMolecular Therapy Nucleic Acids, 2012
- Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug ReleaseACS Nano, 2010
- Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of DoxorubicinPLOS ONE, 2009
- Aptamer-based endocytosis of a lysosomal enzymeProceedings of the National Academy of Sciences, 2008
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006
- Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imagingProceedings of the National Academy of Sciences, 2006